RT Journal Article
SR Electronic
T1 Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2020.04.21.050633
DO 10.1101/2020.04.21.050633
A1 Oude Munnink, Bas B.
A1 Nieuwenhuijse, David F.
A1 Stein, Mart
A1 O’Toole, Áine
A1 Haverkate, Manon
A1 Mollers, Madelief
A1 Kamga, Sandra K.
A1 Schapendonk, Claudia
A1 Pronk, Mark
A1 Lexmond, Pascal
A1 van der Linden, Anne
A1 Bestebroer, Theo
A1 Chestakova, Irina
A1 Overmars, Ronald J.
A1 van Nieuwkoop, Stefan
A1 Molenkamp, Richard
A1 van der Eijk, Annemiek
A1 GeurtsvanKessel, Corine
A1 Vennema, Harry
A1 Meijer, Adam
A1 Rambaut, Andrew
A1 van Dissel, Jaap
A1 Sikkema, Reina S.
A1 Timen, Aura
A1 Koopmans, Marion
A1 ,
YR 2020
UL http://biorxiv.org/content/early/2020/04/25/2020.04.21.050633.abstract
AB SARS-CoV-2 is a novel coronavirus that has rapidly spread across the globe. In the Netherlands, the first case of SARS-CoV-2 has been notified on the 27th of February. Here, we describe the first three weeks of the SARS-CoV-2 outbreak in the Netherlands, which started with several different introductory events from Italy, Austria, Germany and France followed by local amplification in, and later also, outside the South of the Netherlands. The timely generation of whole genome sequences combined with epidemiological investigations facilitated early decision making in an attempt to control local transmission of SARS-CoV-2 in the Netherlands.Competing Interest StatementThe authors have declared no competing interest.